Bigenzahn, S., Juergens, B., Mahr, B., Pratschke, J., Koenigsrainer, A., Becker, T., . . . Wekerle, T. (2018). No augmentation of indoleamine 2,3‐dioxygenase (IDO) activity through belatacept treatment in liver transplant recipients. Clin Exp Immunol.
শিকাগো স্টাইলে সাইটেশনBigenzahn, S., et al. "No Augmentation of Indoleamine 2,3‐dioxygenase (IDO) Activity Through Belatacept Treatment in Liver Transplant Recipients." Clin Exp Immunol 2018.
এমএলএ সাইটেশনBigenzahn, S., et al. "No Augmentation of Indoleamine 2,3‐dioxygenase (IDO) Activity Through Belatacept Treatment in Liver Transplant Recipients." Clin Exp Immunol 2018.
সতর্কবাণী: সাইটেশন সবসময় 100% নির্ভুল হতে পারে না.